Dr. Reddy's Laboratories Limited (RDY) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Dr. Reddy's Laboratories Limited, with annual and quarterly history.
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 23.89x | 16.63x | 18.45x | 17.24x | 29.85x | 3220.81x |
| P/B Ratio | 2.91x | 2.82x | 3.66x | 3.36x | 3.69x | 315.97x |
| P/S Ratio | 3.05x | 2.89x | 3.68x | 3.16x | 3.28x | 292.64x |
| Profitability | ||||||
| Gross Margin | 52.8% | 58.5% | 58.6% | 56.7% | 53.1% | 50.8% |
| Operating Margin | 13.8% | 22.1% | 24.3% | 23.2% | 13.7% | 16.9% |
| Net Margin | 12.8% | 17.4% | 19.9% | 18.3% | 11.0% | 9.1% |
| EBITDA Margin | 20.0% | 29.7% | 31.7% | 30.3% | 21.0% | 20.9% |
| Liquidity | ||||||
| Current Ratio | 1.80x | 1.92x | 2.58x | 2.38x | 1.93x | 1.78x |
| Quick Ratio | 1.35x | 1.37x | 1.92x | 1.81x | 1.39x | 1.23x |
| Leverage | ||||||
| Debt/Equity | 0.21x | 0.14x | 0.07x | 0.06x | 0.18x | 0.18x |
YoY = year-over-year change. Source: FMP..